Caribou Biosciences, Inc. financial data

Symbol
CRBU on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
2929 7 Th Street, Suite 105, Berkeley, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.09 K % +5.72%
Debt-to-equity 19.3 % -16.6%
Return On Equity -33.4 % +3.55%
Return On Assets -28 % +0.43%
Operating Margin -392 % +50.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 90.3 M shares +47.3%
Common Stock, Shares, Outstanding 90.3 M shares +47.3%
Entity Public Float 263 M USD -14.6%
Common Stock, Value, Issued 9 K USD +50%
Weighted Average Number of Shares Outstanding, Basic 89.3 M shares +46%
Weighted Average Number of Shares Outstanding, Diluted 89.3 M shares +46%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 33.4 M USD +127%
Research and Development Expense 120 M USD +27.8%
General and Administrative Expense 44.2 M USD +18.4%
Operating Income (Loss) -131 M USD -12.2%
Nonoperating Income (Expense) 15.9 M USD +90%
Income Tax Expense (Benefit) 193 K USD +176%
Net Income (Loss) Attributable to Parent -115 M USD -6.35%
Earnings Per Share, Basic -1.38 USD/shares +22.5%
Earnings Per Share, Diluted -1.38 USD/shares +22.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 49.4 M USD -6.34%
Marketable Securities, Current 228 M USD
Cash, Cash Equivalents, and Short-term Investments 346 M USD +18.9%
Accounts Receivable, after Allowance for Credit Loss, Current 917 K USD -40.2%
Assets, Current 305 M USD +27.2%
Property, Plant and Equipment, Net 19.2 M USD +51.6%
Operating Lease, Right-of-Use Asset 21.7 M USD -8.67%
Other Assets, Noncurrent 1.79 M USD +21.5%
Assets 407 M USD +17.1%
Accounts Payable, Current 5.94 M USD +124%
Employee-related Liabilities, Current 4.45 M USD +38.3%
Accrued Liabilities, Current 19 M USD +51.4%
Contract with Customer, Liability, Current 2.83 M USD -74%
Liabilities, Current 29 M USD +7.09%
Contract with Customer, Liability, Noncurrent 5.43 M USD -61%
Deferred Income Tax Liabilities, Net 556 K USD +45.6%
Operating Lease, Liability, Noncurrent 25.9 M USD -1.92%
Liabilities 63.5 M USD -8.17%
Accumulated Other Comprehensive Income (Loss), Net of Tax -322 K USD +55.9%
Retained Earnings (Accumulated Deficit) -341 M USD -51.2%
Stockholders' Equity Attributable to Parent 343 M USD +23.4%
Liabilities and Equity 407 M USD +17.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -37.2 M USD -33.2%
Net Cash Provided by (Used in) Financing Activities 12.5 M USD +660%
Net Cash Provided by (Used in) Investing Activities 23 M USD +10.9%
Common Stock, Shares Authorized 300 M shares 0%
Common Stock, Shares, Issued 90.3 M shares +47.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.76 M USD +68.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 49.4 M USD -6.34%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 96.2 M USD +44.8%
Deferred Tax Assets, Gross 105 M USD +36.4%
Operating Lease, Liability 27.2 M USD -0.96%
Payments to Acquire Property, Plant, and Equipment 1.45 M USD -28.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -115 M USD -6.33%
Lessee, Operating Lease, Liability, to be Paid 41 M USD -7.55%
Property, Plant and Equipment, Gross 29 M USD +53.9%
Operating Lease, Liability, Current 1.26 M USD +23.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.72 M USD +27.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.48 M USD +15.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 13.8 M USD -18.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.92 M USD +3.53%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10 M shares 0%
Unrecognized Tax Benefits 4.09 M USD +46.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 6.12 M USD +3.38%
Operating Lease, Payments 711 K USD -35%
Additional Paid in Capital 684 M USD +35.7%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 710 K USD +20.5%
Deferred Tax Assets, Net of Valuation Allowance 8.76 M USD -16.6%
Share-based Payment Arrangement, Expense 14.6 M USD +23.5%
Interest Expense 4 K USD -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%